Exact Mass: 191.098
Exact Mass Matches: 191.098
Found 275 metabolites which its exact mass value is equals to given mass value 191.098,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
trihomomethionine
A sulfur-containing amino acid consisting of 2-aminoheptanoic acid having a methylthio substituent at the 7-position.
N'-nitrosoanabasine
N-Nitrosoanabasine (NAB) is a minor tobacco alkaloid that is derived from the tertiary amine known as anabasine (PMID: 3286030). It belongs to a group of nitrosamines called tobacco-specific nitrosamines (TSNAs). It is thought that during tobacco processing, minor alkaloids such as NAB originate from bacterial action or oxidation (PMID: 29751076). Nitrosamines are chemically stable compounds under physiological conditions, but they are known as causative factors for cancers of the lung, pancreas, esophagus, and oral cavity (PMID: 29751076). Activation of TSNAs through α-hydroxylation leads to binding of TSNA to DNA and other cellular macromolecules. This results in biological actions such as carcinogenicity, mutagenicity, embryopathy and other teratogenic actions (PMID: 4997817). N-nitrosoanabasine is only found in individuals who smoke or who are exposed to tobacco smoke.
Idrocilamide
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant
5-Methoxytryptophol
5-Methoxytryptophol is synthesized by the pineal gland. Daily rhythms in pineal methoxyindole metabolism have been described in rodents and humans (5-Methoxytryptophol levels are coincident with serotonin levels in rodents pineal) and 5-Methoxytryptophol at its highest during the daylight hours and fall markedly soon after the onset of darkness, coincident with increases in the levels of pineal melatonin and the activities of pineal serotonin-N-acetyltransferase (EC 2.3.1.87, SNAT) and hydroxyindole-O-methyltransferase (EC 2.1.1.4, HIOMT). The fact that the levels of 5-methoxytryptophol and melatonin vary in parallel suggests that the major factor generating the methoxyindole rhythms is not SNAT activity, but perhaps a change in the availability (for metabolism) of "stored" serotonin. When the onset of darkness is delayed by 12 hours, human 5-methoxytryptophol (and melatonin) rhythms usually require 3 or 4 days to adjust to the new lighting regimen. Environmental factors, other than light, that activate the sympathetic nervous system or cause epinephrine to be secreted from the adrenal medulla (e.g., the stress of immobilization; insulin-induced hypoglycemia) can override the inhibitory effects of light and accelerate melatonin synthesis. Rhythms in 5-methoxytryptophol (and melatonin) synthesis apparently persist among animals placed in environments of continuous darkness; the source of the cyclic signal (mediated by the pineal sympathetic nerves) has not yet been identified. Preliminary evidence suggests that levels of a peptide hormone, arginine vasotocin, in rat pineal and sera also exhibit daily rhythms and are increased by norepinephrine. The circadian rhythm of melatonin secretion is generated in the suprachiasmatic nucleus. Sleep disruption, nightly restlessness, sundowning, and other circadian disturbances are frequently seen in Alzheimers disease patients. Changes in the suprachiasmatic nucleus and pineal gland are thought to be the biological basis for these behavioral disturbances. (PMID 288858, 2245336) [HMDB] 5-Methoxytryptophol is synthesized by the pineal gland. Daily rhythms in pineal methoxyindole metabolism have been described in rodents and humans (5-Methoxytryptophol levels are coincident with serotonin levels in rodents pineal) and 5-Methoxytryptophol at its highest during the daylight hours and fall markedly soon after the onset of darkness, coincident with increases in the levels of pineal melatonin and the activities of pineal serotonin-N-acetyltransferase (EC 2.3.1.87, SNAT) and hydroxyindole-O-methyltransferase (EC 2.1.1.4, HIOMT). The fact that the levels of 5-methoxytryptophol and melatonin vary in parallel suggests that the major factor generating the methoxyindole rhythms is not SNAT activity, but perhaps a change in the availability (for metabolism) of "stored" serotonin. When the onset of darkness is delayed by 12 hours, human 5-methoxytryptophol (and melatonin) rhythms usually require 3 or 4 days to adjust to the new lighting regimen. Environmental factors, other than light, that activate the sympathetic nervous system or cause epinephrine to be secreted from the adrenal medulla (e.g., the stress of immobilization; insulin-induced hypoglycemia) can override the inhibitory effects of light and accelerate melatonin synthesis. Rhythms in 5-methoxytryptophol (and melatonin) synthesis apparently persist among animals placed in environments of continuous darkness; the source of the cyclic signal (mediated by the pineal sympathetic nerves) has not yet been identified. Preliminary evidence suggests that levels of a peptide hormone, arginine vasotocin, in rat pineal and sera also exhibit daily rhythms and are increased by norepinephrine. The circadian rhythm of melatonin secretion is generated in the suprachiasmatic nucleus. Sleep disruption, nightly restlessness, sundowning, and other circadian disturbances are frequently seen in Alzheimers disease patients. Changes in the suprachiasmatic nucleus and pineal gland are thought to be the biological basis for these behavioral disturbances. (PMID 288858, 2245336). D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants 5-Methoxytryptophol is a natural indole present in the pineal gland.
4-Hydroxycitrulline
4-Hydroxycitrulline is found in pulses. 4-Hydroxycitrulline is isolated from Vicia fab
4-Hydroxydebrisoquine
Debrisoquine is metabolized to 4-hydroxydebrisoquine by CYP2D6. Due to this, it has been used widely to determine the hydroxylation capacity of the enzyme.(PMID:15843230) [HMDB] Debrisoquine is metabolized to 4-hydroxydebrisoquine by CYP2D6. Due to this, it has been used widely to determine the hydroxylation capacity of the enzyme.(PMID:15843230).
(E)-5-(3,4,5,6-Tetrahydro-3-pyridylidenemethyl)-2-furanmethanol
(E)-5-(3,4,5,6-Tetrahydro-3-pyridylidenemethyl)-2-furanmethanol is produced of reaction between glucose and lysine in slightly acid solution. Production of reacn. between glucose and lysine in sl. acid soln.
5-Methoxytryptophol
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants 5-Methoxytryptophol is a natural indole present in the pineal gland.
4-Hydroxydebrisoquin
An isoquinoline that is 3,4-dihydroisoquinoline bearing amidino and hydroxy substituent at positions 2 and 4 respectively.
Methoxytryptophol
5-Methoxytryptophol is a natural indole present in the pineal gland.
(E)-5-(3,4,5,6-Tetrahydro-3-pyridylidenemethyl)-2-furanmethanol
methyl 4-amino-2,3-dihydro-1H-indene-2-carboxylate
Cyclopropanecarboxylic acid, 1-[(phenylmethyl)amino]- (9CI)
1-(4-METHOXY-PHENYL)-4,5-DIHYDRO-1H-PYRAZOL-3-YLAMINE
1H-Indene-1-carboxylicacid,1-amino-2,3-dihydro-,methylester,(S)-(9CI)
2-AMINO-7,7-DIMETHYL-7,8-DIHYDRO-6H-QUINAZOLIN-5-ONE
1,3-Dioxolo[4,5-g]isoquinoline, 5,6,7, 8-tetrahydro-6-methyl-
1-ethenyl-4,5,6,7-tetrahydroindole-2-carboxylic acid
Pyrido[3,4-b]pyrazine, 4-acetyl-1,2,3,4-tetrahydro-1-methyl- (9CI)
Benzoic acid, 2-amino-3-(2-propenyl)-, methyl ester (9CI)
(S)-2-Amino-1,2,3,4-tetrahydro-2-naphthalenecarboxylic acid
Quinoxaline, 1,2,3,4-tetrahydro-2,4-dimethyl-1-nitroso- (9CI)
1-(2-METHYL-2,3-DIHYDROBENZO[B]FURAN-5-YL)ETHAN-1-ONE OXIME
1,3,4,5-TETRAHYDRO-7-METHOXY-2H-1-BENZAZEPIN-2-ONE
2-METHYL-1,2,3,4-TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID
Methyl 1,2,3,4-tetrahydroisoquinoline-5-carboxylate
3-[(Cyclopropylmethoxy)methyl]pyrrolidine hydrochloride
Carbamic acid, [2-(methylthio)ethyl]-, 1,1-dimethylethyl ester (9CI)
methyl 1,2,3,4-tetrahydroisoquinoline-7-carboxylate
2-(Dimethylaminomethyl)-1-cyclohexanone hydrochloride
3,4,7,8,9,10-HEXAHYDROPYRAZINO[1,2-B]INDAZOL-1(2H)-ONE
Methyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate
5,6,7,8-TETRAHYDRONAPHTHO[2,3-D][1,3]DIOXOL-6-AMINE
1,2,3,4-Tetrahydro-isoquinoline-1-carboxylic acid methyl ester
2-Naphthalenecarboxylicacid, 2-amino-1,2,3,4-tetrahydro-
2-Naphthalenecarboxylicacid,8-amino-5,6,7,8-tetrahydro-(9CI)
5-methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
Pyrido[2,3-b]pyrazine, 1-acetyl-1,2,3,4-tetrahydro-4-methyl- (9CI)
1-Methyl-1,2,3,4-tetrahydroquinoline-6-carboxylic acid
Ethanol, 2-[(5-methyl-1H-benzimidazol-2-yl)amino]- (9CI)
3,4-dihydroisoquinolin-2(1H)-ylacetic acid(SALTDATA: HCl)
1,3-Dimethyl-5-methoxy-2,3-dihydro-1H-indole-2-one
1-(8-hydroxy-3,4-dihydroisoquinolin-2(1H)-yl)ethanone
1-(5-hydroxy-3,4-dihydro-1H-isoquinolin-2-yl)ethanone
(2-ethyl-7-methyl-1H-imidazo[4,5-b]pyridin-5-yl)methanol
METHYL 1,2,3,4-TETRAHYDROISOQUINOLIN-8-CARBOXYLATE
1H-Benzimidazol-5-ol,4-[(dimethylamino)methyl]-(9CI)
5-Amino-2,3-dihydro-1H-indene-1-carboxylic acid methyl ester
6-amino-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid
Ethanol, 2-[(1-methyl-1H-benzimidazol-2-yl)amino]- (9CI)
L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid methyl ester hydrochloride
(S)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID METHYL ESTER
Trans-1H-Indene-2-carboxylicacid,1-amino-2,3-dihydro-,ethylester
(3R)-3-amino-2,3-dihydro-1H-indene-5-carboxylic acid methyl ester
7-amino-4,4-dimethyl-3,4-dihydro-1,8-naphthyridin-2(1H)-one
Imeglimin hydrochloride
Imeglimin hydrochloride (EMD 387008) is an oral glucose-lowering agent. Imeglimin also reduces reactive oxygen species (ROS) production, increases mitochondrial DNA and improves mitochondrial function[1].
Ethanone, 1-[(2S)-2,3-dihydro-2-(hydroxyMethyl)-1H-indol-1-yl]-
(4AS,8AS)-OCTAHYDRO-ISOQUINOLIN-4A-OL HYDROCHLORIDE
1H-Benzimidazole-1-ethanol,alpha-(aminomethyl)-(9CI)
(R)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXYLIC ACID METHYL ESTER
5-AMINOMETHYL-1,3-DIMETHYL-1,3-DIHYDRO-BENZOIMIDAZOL-2-ONE
methyl 1,2,3,4-tetrahydroisoquinoline-6-carboxylate
(R)-2-Amino-2-(2,3-dihydro-1H-inden-2-yl)acetic acid
Phenol, 2-[[3-hydroxy-1-methyl-2-buten-1-ylidene]amino]-
6-ethyl-2,7-dimethyl-1H-pyrazolo[1,5-a]pyrimidin-5-one
3-Ethyl-1,3-dihydro-3-methoxy-2H-indol-2-one
An oxindole that is 1,3-dihydro-2H-indol-2-one which is substituted by ethyl and methoxy groups at position 3.
L-trihomomethionine
An L-polyhomomethionine in which there are five methylene groups between the alpha-carbon and sulfur atoms.
(2S,3E)-2-Amino-4-[(2R)-2-amino-3-hydroxypropoxy]but-3-enoate
4-amino-3-hydroxy-6-methylheptanethioic S-acid
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors
4-(1,2,3,6-Tetrahydropyridin-4-yl)benzene-1,2-diol
3H,4H-3-Tert-butylpyrro(1,2-D)(1,2,4)triazin-4-one
Rhizobitoxine
If you can find information about the stereoconfiguration of the second amino group, you are very welcome to add it.
L-trihomomethionine zwitterion
An L-polyhomomethionine zwitterion obtained by transfer of a proton from the carboxy to the amino group of L-trihomomethionine; major species at pH 7.3.
